StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30234% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Antidilutive Securities Excluded from Diluted EPS by Quarter

Antidilutive Securities Excluded from Diluted EPS: RSUs & Performance Awards (thousand shares)

Natera Antidilutive Securities Excluded from Diluted EPS: 7,321.00 k_shares in Q2 2026, down 22.9% from a year earlier.

Latest, Q2 2026
7,321.00
Period ended Jun 30, 2026
Change on a year earlier
-22.9%
9,498.00 in Q2 2025
History
22 quarters
Since Q1 2021
Sources
17
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (2026-08-07) ↗

Reported in Form 10-K/10-Q Note — Net Loss Per Share (XBRL).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAntidilutive Securities Excluded from Diluted EPS: RSUs & Performance Awards (thousand shares)Year on yearSource
Q2 2026Jun 30, 20267,321.00-22.9%Form 10-Q (2026-08-07) ↗
Q1 2026Mar 31, 20267,949.00-20.3%Form 10-Q (2026-05-08) ↗
Q4 2025Dec 31, 20258,323.00-21.4%Form 10-K (2026-02-27) ↗
Q3 2025Sep 30, 20258,893.00-18.1%Form 10-Q (2025-11-07) ↗
Q2 2025Jun 30, 20259,498.00-16.2%Form 10-Q (2026-08-07) ↗
Q1 2025Mar 31, 20259,974.00-16.2%Form 10-Q (2026-05-08) ↗
Q4 2024Dec 31, 202410,593.00+14.5%Form 10-K (2026-02-27) ↗
Q3 2024Sep 30, 202410,856.00+15.0%Form 10-Q (2025-11-07) ↗
Q2 2024Jun 30, 202411,338.00+17.4%Form 10-Q (2025-08-08) ↗
Q1 2024Mar 31, 202411,901.00+14.9%Form 10-Q (2025-05-09) ↗
Q4 2023Dec 31, 20239,248.00+35.3%Form 10-K (2026-02-27) ↗
Q3 2023Sep 30, 20239,440.00+30.3%Form 10-Q (2024-11-12) ↗
Q2 2023Jun 30, 20239,658.00+27.1%Form 10-Q (2024-08-09) ↗
Q1 2023Mar 31, 202310,356.00+38.3%Form 10-Q (2024-05-10) ↗
Q4 2022Dec 31, 20226,836.00+71.4%Form 10-K (2025-02-28) ↗
Q3 2022Sep 30, 20227,243.00+91.5%Form 10-Q (2023-11-09) ↗

Breakdown

What makes up antidilutive Securities Excluded from Diluted EPS

Cite this data

StockData. (2026). Natera Antidilutive Securities Excluded from Diluted EPS, quarterly Q1 2021–Q2 2026 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/antidilutive-rsu-perf-shares

See every metric in the Natera KPI table. Data updated Nov 2, 2026.